Results 41 to 50 of about 1,729,719 (389)

Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in Women.

open access: yesJournal of the American Medical Association (JAMA), 2016
Importance Human papillomavirus (HPV) infections cause anogenital cancers and warts. The 9-valent HPV vaccine provides protection against 7 high-risk types of HPV responsible for 90% of cervical cancers and 2 other HPV types accounting for 90% of genital
O. Iversen   +20 more
semanticscholar   +1 more source

The efficacy of halofantrine in the treatment of acute malaria in nonimmune travelers [PDF]

open access: yes, 1992
A multicenter prospective trial was performed to investigate the efficacy and the tolerability of halofantrine in nonimmune patients with malaria imported from areas with drug-resistant falciparum parasites (mainly Africa).
Bock, H. L.   +8 more
core   +1 more source

The CHART Regimen and Morbidity [PDF]

open access: yesActa Oncologica, 1999
In 1984, when the CHART regime was devised, it was predicted that acute reactions in skin and mucosae would be more severe but that there would be a considerable reduction of late effects in normal tissues. The findings from the pilot study conducted from 1985 to 1990 and from the randomized trials, which entered cases from 1990 to 1995, are reviewed ...
Michele I. Saunders, Stanley Dische
openaire   +3 more sources

MRSA eradication of newly acquired lower respiratory tract infection in cystic fibrosis [PDF]

open access: yes, 2016
UK cystic fibrosis (CF) guidelines recommend eradication of methicillin-resistant Staphylococcus aureus (MRSA) when cultured from respiratory samples.
Downey, DG   +7 more
core   +3 more sources

BLOOD GLUCOSE TARGET ACHIEVEMENT AND ANTIDIABETES REGIMEN IN TYPE-2 DIABETIC GERIATRIC PATIENTS

open access: yesIndonesian Journal of Pharmacy, 2014
Diabetes mellitus (DM) is a leading caused morbidity in geriatric patients. The prevalence of type-2 DM is more than 90% of DM population and increase with age, and half of those patients were geriatric.
Budi Suprapti   +3 more
doaj   +1 more source

A four-month gatifloxacin-containing regimen for treating tuberculosis.

open access: yesNew England Journal of Medicine, 2015
T; Odhiambo, J; Amukoye, E; Bah, B; Kassa, F; N’Diaye, A; Rustomjee, R; de Jong, BC; Horton, J; Perronne, C; Sismanidis, C; Lapujade, O; Olliaro, PL; Lienhardt, C; OFLOTUB/Gatifloxacin for Tuberculosis Project, ; , COLLABORATORS; Billy, C; Bah, H; Bah, M;
C. Merle   +6 more
semanticscholar   +1 more source

Weekly versus three weeks chemotherapy for advanced ovarian cancer. A meta-analysis [PDF]

open access: yes, 2016
Aim: Three weeks paclitaxel and carboplatin has been considered the standard of care for primary treatment of ovarian cancer (OC). Whether weekly therapy will further improve the clinical outcomes or not is still unclear.
De Felice, Francesca   +8 more
core   +1 more source

Psoriasis Vulgaris Successfully Treated with Goeckerman Treatment at Home: A Patient and Physician's Experience. [PDF]

open access: yes, 2020
Goeckerman therapy is a highly effective treatment regimen for moderate-to-severe psoriasis. It involves regular exposure to ultraviolet B radiation and the application of crude coal tar.
Bhutani, Tina   +5 more
core  

Patient involvement in selection of immunosuppressive regimen following transplantation. [PDF]

open access: yes, 2014
Transplantation has made a considerable difference to the lives of many patients. However, feedback from patients indicates that although having a transplant is a hugely positive experience, having to take medications indefinitely is one of the biggest ...
Greene, H   +3 more
core   +1 more source

Evaluation of the Surgical and Pharmacological Treatment of Diabetic Foot Infection: A Retrospective Study [PDF]

open access: yes, 2017
BACKGROUND: Diabetic foot infection is a major cause of patient disabilities and lowers limb amputations, with high treatment costs and hospitalisation requirements.
Aliakbar, Adil Hassan   +2 more
core   +4 more sources

Home - About - Disclaimer - Privacy